High sensitivity of analysis is constantly in demand in biomedical research and clinical diagnosis. In recent years aptamer-based analytical methods have been developed for protein detection. We developed a cascade signal amplification strategy based on molecular switches and aptamers to improve protein detection.
BACKGROUND:
High sensitivity of analysis is constantly in demand in biomedical research and clinical diagnosis. In recent years aptamer-based analytical methods have been developed for protein detection. We developed a cascade signal amplification strategy based on molecular switches and aptamers to improve protein detection.
METHODS:
Our cascade signal amplification strategy based on molecular switches and aptamers consisted of 2 steps, including the recognition and the triggering of a polymerase reaction. The procedure was designed to simplify the analysis by detecting trace amounts of target isothermally, in real time, and in a homogeneous solution. We applied this method to measure thrombin in human serum samples.
RESULTS:
This cascade signal amplification strategy exhibited a linear response in thrombin concentration from 0.3 to 10 nmol/L, with a detection limit of 1.7 ϫ 10 Ϫ10 mol/L within 60 min. Results of the analysis of thrombin in human serum diluted 1:1 appeared to be linear, as was observed in buffer, in the tested concentration range of 0.3-10 nmol/L.
CONCLUSIONS:
The aptameric sensor provides promising potential for detecting and screening trace concentrations of biomarkers in complex matrices for clinical applications.
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High sensitivity of analysis is constantly in demand for clinical diagnosis. Thus, the development of assay signal amplification paths has become important, and several amplification techniques have been developed, including catalytic nanoparticles (1, 2 ) , PCR (3, 4 ) , rolling-circle amplification (5, 6 ) , enzyme-triggered strand displacement amplification (7) (8) (9) (10) , entropydriven signal amplification (11, 12 ) , and cascade signal amplification (13, 14 ) . The PCR is currently the most widely used thermal-cycling technique for DNA amplification. However, thermal-cycling techniques require the use of special instruments, and the conventional PCR product typically requires characterization at the end of the reaction (13 ). These disadvantages limit this technique. Isothermal amplification of DNA has emerged as an alternative amplification technique (6, 8, 15 ) . The reaction is performed at a constant temperature, so the time required for DNA amplification is less than that of thermal-cycling techniques. In addition, isothermal amplification can be performed without specialized instrumentation and has the potential for use in point-of-care testing. The basis of this technique is continuous strand displacement, in which polymerase extension uses 1 strand of the DNA chain as a template (16 ) . He et al. (8 ) described an analytically sensitive method for cocaine detection based on isothermal strand displacement. Shlyahovsky et al. (7 ) provided an automated technique based on aptamers that was activated by polymerase, nicking enzyme, and a molecular beacon for amplifying the detection of cocaine. The advantage of these fluorescent biosensors was an enhanced limit of detection of the assay, whereas the linear signal amplification procedure seemed to be disadvantageous.
Aptamers have been integrated as recognition elements in optical or electrochemical sensors (17, 18 ) . Aptamers are nucleic acids selected from a rich nucleic acid library by means of the SELEX (systematic evolution of ligands by exponential enrichment) procedure. Aptamers possess specific recognition properties toward low molecular weight substrates or macromolecules such as proteins (19 ) . As novel elements for molecular recognition, aptamers offer many advantages over protein antibodies, such as high affinity and specificity for target proteins, good stability, and ease of synthesis and modification (20 ) . Aptamer-based analytical methods have been developed for protein-detection methods that use electrochemistry (21, 22 ) , fluorescence (23, 24 ) , and bindinginduced label-free detection (25 ) .
Thrombin is a serine protease that plays an important role in the coagulation cascade, thrombosis, and hemostasis. The 15mer single-strand DNA of the thrombin aptamer can bind with thrombin strongly and selectively and is the first aptamer selected in vitro (26 ) . The goal of our study was to develop a highly selective and sensitive aptamer-based sensor to detect thrombin in human serum. We have introduced the paradigm of a signal amplification platform that isothermally and nonlinearly amplifies the recognition event between the aptamer and its substrate. The readout of the analysis triggered by binding of the aptamer and substrate was have accomplished by a fluorescence signal. We have developed a cascade signal amplification strategy that is isothermal and homogeneous.
Materials and Methods
All oligonucleotides used in this work were designed by using the mFold server (http://mfold.rna.albany. edu) and synthesized by Takara Biotechnology, as shown in Table 1 .
Klenow fragment polymerase (exo Ϫ ), Nt.BbvCI enzyme, and a mixture of deoxynucleoside triphosphates (dNTPs) 2 were purchased from New England Biolabs. Human thrombin (10 U/mg) was purchased from DingGuo. BSA was obtained from Westang. Trypsin and bovine thrombin were purchased from Sigma-Aldrich. Human serum was provided by Qingdao Municipal Hospital in China. All chemicals were of analytical grade and were used without further purification. All solutions were prepared with doubly distilled water. 1A ). Region I is the sequence of thrombin aptamer. The 7 bases at the 5Јterminus excluded from the stem of nucleic acid 1 are for a better switching of the DNA structure. Region II consists of a sequence that is the same as a molecular beacon. Thus, the complementary strand of region II can act as the "product" and hybridize with the molecular beacon when it is replicated and displaced, which leads to the signal transduction of the thrombin-binding event. Region III includes a nicking site for Nt.BbvCI when the duplex of this region is formed. Region IV is located in the 3Јterminus of nucleic acid 1, which can hybridize with region I for 10 bases or for 7 bases with itself. Therefore, nucleic acid 1 has 2 kinds of configurations in solution. Owing to the hybridization of 10 bases by nucleic acid 1 with higher affinity than the hybridization of 7 bases, most of nucleic acid 1 exists in the state of region I hybridizing with region IV in the absence of thrombin. This prevents uncontrolled folding of nucleic acid 1 from triggering the polymerase reaction. In addition, region IV has 2-base extensions at the 3Ј terminus to avoid undesired replication reactions under experimental conditions.
In the presence of thrombin, nucleic acid 1 acts as a molecular switch, folding the aptamer into its stable aptamer-thrombin complex (Fig. 1B) and forming a 7-base duplex structure with itself that can initiate replication. The 15mer thrombin aptamer appears to have a dissociation constant (K d ) from 25 to 200 nmol/L for thrombin (26 ) , whereas the Klenow fragment polymerase has a K d of 7.9 nmol/L for DNA (27 ) . The thrombin aptamer has a greater K d for thrombin than the polymerase for DNA, so the polymerase is able to displace thrombin from the furled-up pocket on the 5Ј terminus. The polymerase replication is activated with the Klenow fragment (exo Ϫ ) and dNTPs and can displace thrombin to another nucleic acid 1. Simultaneously, the replication of a single strand yields the duplex that includes the nicking site for Nt.BbvCI. Scission of the replicated strand results in a new replication site for polymerase and the concomitant dis- placement of the nicked strand. Thus, there are double circular amplifications to produce cascade signal amplification by thrombin displacement and the nicking method. The circle with a slashed line through it (Fig.  1B ) means no presence of thrombin, so no cascade signal amplification is generated. The system also includes nucleic acid 3 as a reporter unit that is a single-strand DNA molecular beacon (DNA-MB). It recognizes and hybridizes with nucleic acid 2. nm) has only a residually minute emission in the absence of nucleic acid 2. In contrast, the fluorescence of FAM shows a large increase in the presence of nucleic acid 2.
TIME-DEPENDENT SENSING PROCEDURE
For real-time monitoring of the reaction process, the reaction was performed by using an ABI StepOne realtime PCR instrument (Applied Biosystems). Nucleic acid 1 was denatured at 95°C for 10 min and cooled to room temperature in 1ϫ NEB buffer 4 (New England Biolabs) [20 mmol/L Tris-acetate (pH 7.9), 50 mmol/L potassium acetate, 10 mmol/L magnesium acetate, and 1 mmol/L dithiothreitol]. Each reaction mixture contained the following reagents in a final volume of 25 L: 1.25 U polymerase, 2.5 U Nt.BbvCI, 0.2 mmol/L dNTPs, 0.4 mol/L nucleic acid 1, and 0.5 mol/L molecular beacon. Reaction buffer was 1ϫ NEB buffer 4. A 5-L specific concentration of thrombin was added to trigger the polymerase reaction. The reactions were incubated at 37°C for 60 min to detect fluorescence intensities. Fluorescence curves were recorded at 30-s intervals. All the reactions were run in triplicate, and the same reaction mixtures without thrombin were used as negative controls.
APPLICATION OF THE APTAMER-BASED SYSTEM IN HUMAN

SERUM
Thrombin was further tested in human serum without any pretreatment to illustrate the feasibility of the approach. Serum, diluted 2 times, was tested alone or spiked with serially diluted thrombin at concentrations ranging from 0.3 to 300 nmol/L. Furthermore, the final concentrations of 3.0 ϫ 10 Ϫ6 mol/L BSA, 10 Ϫ7 mol/L trypsin, and 10 Ϫ7 mol/L bovine thrombin were tested in the selectivity experiments. The assay procedures for BSA, trypsin, and bovine thrombin were the same as those for human thrombin in buffer, except for the use of BSA, trypsin, and bovine thrombin instead of human thrombin, respectively.
Results and Discussion
A time course of signal cascade amplification reactions initiated with different amounts of thrombin is shown in Fig. 2A . The progress of the reaction was visualized by using denaturing PAGE (20% separation gel, 5% spacer gel). The results of the electrophoresis confirmed the expected amplification reaction and the presence of nucleic acid 2 ( Fig. 2A, inset) . Consistent with electrophoresis results, the fluorescence response increased with the increases in reaction time and in thrombin concentrations ranging from 0.3 nmol/L to 300 nmol/L (Fig. 2A) . The change in fluorescence signal (⌬F) was calculated as F Ϫ F 0 , where F and F 0 correspond to the fluorescence emission intensity observed in the presence and absence of a given thrombin concentration, respectively. The ⌬F continued to increase with the increase in thrombin concentration (0.3 to 300 nmol/L) until a plateau was reached (Fig.  2B) . A linear relationship between the ⌬F and the logarithm of thrombin concentration from 0.3 to 10 nmol/L for thrombin quantification was found (Fig.  2B, inset) , with a correlation coefficient of 0.9964. The regression equation was: ⌬F ϭ 12 710 ϫ logC ϩ 590 (C is the concentration of thrombin, 10 -10 mol/L). The detection limit for thrombin was determined to be 1.7 ϫ 10 Ϫ10 mol/L with the use of the 3 value of the background signal ( n ϭ 7). This low detection limit for thrombin was attributable to the large signal amplification upon target-induced polymerization. This detection limit was comparable to or better than that of other reported aptamer-based fluorescence analytical methods for thrombin detection listed in Supplemental Table 1 (see the Data Supplement that accompanies the online version of this article at http://www. clinchem.org/content/vol58/issue2). Considering the low specific activity of thrombin (10 U/mg) used in this experiment and the high specific activity of thrombin (1000 -3600 U/mg) in most of the reported methods, this method should have a lower detection limit. Control experiments revealed that the approach generated a small background fluorescence of FAM in the absence of thrombin. This background fluorescence was attributed to minute quantities of nucleic acid 1 folding into a 7-base duplex to activate replication even in the absence of thrombin.
Recently, Connolly et al. (13 ) developed a cascade signal amplification strategy for rapid quantification of DNA. The fluorescence signal quickly increased with the increase of target DNA. This is an intelligent method and can be used to detect trace amounts of DNA. However, the disadvantage of this method is the ability to detect and amplify only a specific DNA sequence. In comparison with this method (13 ), our approach can detect and quantify various non-DNA biomarkers on the basis of the recognition abilities of aptamers for different target molecules, such as proteins and small molecules.
We tested the specificity of the assay with BSA, trypsin, and bovine thrombin. Because of the inherent specificity of the aptamer toward its target, the sensing system was highly specific (Fig. 3) . Only thrombin caused remarkable signal amplification, and the signal was about 7 times higher than that of BSA, trypsin, and bovine thrombin (BSA, trypsin, and bovine thrombin caused negligible ⌬F). The experimental results indicated that the developed assay could exhibit a high degree of selectivity for thrombin detection and was suitable for the detection of thrombin in a real sample. Ϫ10 mol/L; r ϭ 0.9987). This result showed that our approach could be used in a complex buffer or real specimens, such as human serum. Thus, this approach appears to be a potentially useful tool to detect the target in complex matrices, and could have broad applications in the fields of basic and clinic research and diagnostics.
In this study, we developed a new aptameric sensor with nonlinear signal amplification, the application of which was demonstrated by the homogeneous detection of thrombin. The new protocol design exhibits the following advantages. First, it mimics the cascade signal amplification strategy used in a biological circuit and can quickly amplify signals under double circular amplifications by thrombin displacement and the nicking method. In our study, this strategy permitted detection at a concentration as low as 0.17 nmol/L thrombin within 60 min. In comparison with the established aptamer-based thrombin system, the amplification of fluorescence signal induced by double circular amplifications improves the detection limit of the assay. Second, the sensor enables simple, isothermal, real-time, and homogeneous detection of targets in human serum (see online Supplemental Fig. 1 ). On the basis of the recognition abilities of aptamers for different molecules, coupled with the high sensitivity, inherent simplicity, and low cost derived from this design strategy, this approach appears promising for detecting and screening trace concentrations of biomarkers in complex matrices in clinical applications. 
